This inventor holds 2 USPTO granted patents. Top assignee: Medarex Inc.. Active years: 2007-2008.
Company Filing History:
Years Active: 2007-2008
Title: The Innovative Contributions of Deborah Maguire
Introduction
Deborah Maguire is a prominent inventor based in Paris, France. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 2 patents to her name, her work has the potential to impact medical diagnostics and treatment.
Latest Patents
Maguire's latest patents focus on monoclonal antibodies against the interferon receptor, specifically targeting type I interferon. The first patent describes a monoclonal antibody directed against the human interferon class I receptor (IFN-R). This antibody is characterized by its ability to recognize the extracellular domain of the human IFN-R and possesses a neutralizing capacity against the biological properties of human type I-IFN. Furthermore, it outlines the use of these antibodies for diagnostic purposes.
Career Highlights
Deborah Maguire is currently associated with Medarex Inc., a company known for its innovative approaches in the field of immunotherapy. Her work at Medarex has allowed her to explore the therapeutic potential of her inventions, contributing to advancements in medical science.
Collaborations
Maguire has collaborated with notable colleagues such as Ivan Plavec and Francois Meyer. These partnerships have fostered a collaborative environment that enhances the research and development of her innovative ideas.
Conclusion
Deborah Maguire's contributions to the field of biotechnology through her patents on monoclonal antibodies demonstrate her commitment to advancing medical science. Her work not only showcases her innovative spirit but also highlights the importance of collaboration in achieving significant breakthroughs.